Ventana Biotech, Inc.
OTC: VNTA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Financial Services
- Industry
- Shell Companies
- CEO
- Janne Christensen
- Headquarters
- Denver, Switzerland
- IPO year
- 2009
- Market cap
- $173.5K
- Website
- https://www.launchpadcafe.net
Loading VNTA…
Loading profile data…Frequently asked questions about VNTA
What does Ventana Biotech, Inc. (VNTA) do?
Ventana Biotech, Inc. is an emerging biotechnology enterprise focused on the lifecycle of drug candidates for personalized medicine, encompassing the identification, assessment, acquisition, development, and eventual commercialization through partnerships of relevant intellectual property. The company's primary therapeutic area is addressing obe...
Where does VNTA trade?
Ventana Biotech, Inc. (VNTA) trades on the Other OTC.
What sector is VNTA in?
Ventana Biotech, Inc. (VNTA) operates in the Financial Services sector, specifically in the Shell Companies industry.
Who is the CEO of Ventana Biotech, Inc.?
Janne Christensen is the chief executive officer of Ventana Biotech, Inc. (VNTA).
Where is Ventana Biotech, Inc. headquartered?
Ventana Biotech, Inc. is headquartered in Switzerland.
Does VNTA pay a dividend?
Ventana Biotech, Inc. (VNTA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VNTA go public?
Ventana Biotech, Inc. (VNTA) completed its initial public offering in 2009.